Association between Glaucoma Medication Usage and Dry Eye in Taiwan

Area of Science:

• Ophthalmology
• Pharmacology
• Epidemiology

Background:

• Glaucoma is a leading cause of irreversible blindness.
• Dry eye disease is a common ocular surface condition.
• The relationship between glaucoma medications and dry eye requires further investigation.

Purpose of the Study:

• To investigate the association between glaucoma medication use and the incidence of dry eye disease.
• To analyze the risk of dry eye based on the type and number of glaucoma drugs used.
• To evaluate these relationships in a nationally representative sample from Taiwan.

Main Methods:

• A population-based, case-control study using Taiwan claims data (2000-2011).
• Identified 2065 glaucoma patients with newly diagnosed dry eye and 8260 matched controls without dry eye.
• Analyzed six classes of glaucoma medications (prostaglandin analogs, beta-blockers, carbonic anhydrase inhibitors, alpha-agonists, pilocarpine, combination drugs) using logistic regression.

Main Results:

• All analyzed glaucoma medications, except alpha-agonists, were associated with an increased risk of dry eye.
• A dose-response relationship was observed, with higher numbers of glaucoma medications correlating with increased dry eye risk.
• Increased dry eye risk was noted in both sexes, with a particular trend in females and those using more than two medication types.

Conclusions:

• Glaucoma medication use is linked to a higher risk of developing dry eye disease.
• The risk escalates with the number of different glaucoma drugs prescribed.
• Healthcare providers should exercise caution and consider potential ocular surface side effects when managing glaucoma patients.